-
A Systematic Review of SNPs Screening for Platinum-Related Pharmacodynamics and Pharmacokinetics Genes in Non-Small Cell Lung Cancer for Precision Medicine
26 Jun 2025 22:33 GMT
… with drugs such as gefitinib, marked a significant milestone … lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. … non-small cell lung cancer patients. Lung Cancer. 2011;72(2 … lung cancer: 2009 looking toward 2012. Chin J Lung Cancer. …
-
DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
24 Jun 2025 11:26 GMT
… small cell lung cancer
Nearly 2.5 million lung cancer cases … including TAGRISSO and IRESSA (gefitinib); IMFINZI and IMJUDO; ENHERTU … in non-small cell lung cancer. Translational Lung Cancer Research. 2015;4 … TROP2 in non-small lung cancers and its correlation …
-
Biomarker and Prognostic Value of Super-ARMS Detection for EGFR Mutation in Advanced NSCLC
07 Jul 2025 20:59 GMT
… cell lung cancer (NSCLC), which accounts for over 80%1 of all lung cancers, is … diagnostic assessment for lung cancer: a medicare claims analysis. Clin Lung Cancer. 2017;18 … -small cell lung cancer as a predictor of response to gefitinib. Onco Targets …
-
MHRA approves SFL’s Aumseqa to treat EGFR-mutated lung cancer in adults
09 Jun 2025 11:29 GMT
… subset of non-small cell lung cancer (NSCLC) patients.
The oral drug … ,000 people are diagnosed with lung cancer every year in the UK … to slow or stop the lung cancer from growing, as well reduce … death by 54% compared to gefitinib, an approved cancer drug, in …
-
UK MHRA approves SFL Pharmaceuticals' aumolertinib to treat non─small cell lung cancer
04 Jun 2025 05:33 GMT
… patients with non-small cell lung cancer (NSCLC).
The new marketing … advanced non-small cell lung cancer who have tested positive … slow or stop the lung cancer from growing. It may … already-approved cancer treatment called gefitinib.
Like all medicines, this …
-
Advancements in Nanocarrier Delivery Systems for Photodynamic Therapy in Lung Cancer
28 May 2025 23:23 GMT
… has surpassed lung cancer in incidence, lung cancer remains the … -stage lung cancer.65 In 2002, Japanese lung cancer treatment … stage central lung cancer.68 However, most lung cancer cases … bypass pathways associated with gefitinib resistance. Additionally, …
-
Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
28 May 2025 22:23 GMT
… patients with non-small cell lung cancer, colorectal cancer and others, according … , such as non-small cell lung cancer, colorectal cancer, pancreatic cancer, … (panitumumab), Tarceva (erlotinib) and Iressa (gefitinib) — are effective cancer therapies but …
-
Elucidating the Role of FASN in Lung Cancer Stem Cells in Sensitive and Resistant EGFR-Mutated Non-Small Cell Lung Cancer Cells
27 May 2025 12:02 GMT
… in patients with lung cancer harboring EGFR mutations … NSCLC, non-small cell lung cancer; PCL-ES, polycaprolactone electrospun … non–small-cell lung cancer to gefitinib. N Engl J … al. Three-dimensional lung tumor microenvironment modulates therapeutic compound …
-
Rewrite The APPLE’s core question—upfront osimertinib versus the sequential approach for EGFR mutated non-small cell lung cancer this news headline for the science magazine post
06 May 2025 19:42 GMT
… small-cell lung cancer (NSCLC): EORTC Lung Cancer Group … Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer … versus Caucasian lung cancer patientsbrain metastasis control … -small cell lung cancer trialsosimertinib treatment …
-
Innovent Announces NMPA Approval Of Limertinib, A Third-Generation EGFR TKI Collaborated With ASK Pharma, For The First-Line Treatment Of Lung Cancer
26 Apr 2025 02:14 GMT
… receive either limertinib or gefitinib. The primary endpoint … of precision therapies for lung cancer-including limertinib, Retsevmo®( … non-small-cell lung cancer (NSCLC)
Lung cancer remains one of … mutated non-small cell lung cancer (NSCLC), who have …
About
© 1995-2025